Estrella Immunopharma, Inc. (ESLA)
1 Item 5.02 filing since 2026-10-29 · roles: CEO. Nasdaq. Biological Products, (No Diagnostic Substances). State: CA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 70 | 2026-10-29 | Appointment | CEO | subscribers | — | Estrella Immunopharma, Inc. (ESLA): CEO Cynthia Pussinen appointed |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works